Emmens Matthew
Insider CIK 1298332 · BMY Director · VRTX Executive Chairman, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2021-03-31 | 2021-04-02 | 574 | $63.13 | $36.2K | 26,999 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2021-02-01 | 2021-02-03 | 3,054 | $62.21 | $190.0K | 26,425 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2020-12-31 | 2021-01-05 | 584 | $62.03 | $36.3K | 23,188 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2020-09-30 | 2020-10-02 | 601 | $60.29 | $36.2K | 22,434 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2020-06-30 | 2020-07-02 | 617 | $58.80 | $36.3K | 21,668 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2020-03-31 | 2020-04-02 | 650 | $55.74 | $36.2K | 20,895 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2020-02-01 | 2020-02-04 | 3,018 | $62.95 | $190.0K | 20,245 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-12-31 | 2020-01-03 | 565 | $64.19 | $36.3K | 17,105 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-09-30 | 2019-10-02 | 715 | $50.71 | $36.3K | 16,423 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-06-30 | 2019-07-02 | 768 | $45.35 | $34.8K | 15,567 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-03-31 | 2019-04-02 | 681 | $47.71 | $32.5K | 14,670 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-02-01 | 2019-02-05 | 3,708 | $49.89 | $185.0K | 13,989 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2018-12-31 | 2019-01-03 | 625 | $51.98 | $32.5K | 10,064 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2018-09-30 | 2018-10-02 | 524 | $62.08 | $32.5K | 9,439 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2018-06-30 | 2018-07-03 | 587 | $55.34 | $32.5K | 8,916 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2018-03-31 | 2018-04-03 | 514 | $63.25 | $32.5K | 8,265 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2018-02-01 | 2018-02-05 | 2,946 | $62.80 | $185.0K | 7,752 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2017-12-31 | 2018-01-03 | 530 | $61.28 | $32.5K | 4,775 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2017-09-30 | 2017-10-03 | 510 | $63.74 | $32.5K | 4,219 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2017-06-30 | 2017-07-05 | 537 | $55.72 | $29.9K | 3,683 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2017-03-31 | 2017-04-04 | 199 | $54.38 | $10.8K | 3,124 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2017-02-21 | 2017-02-23 | 2,925 | $54.78 | $160.2K | 2,925 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2012-11-16 | 2012-11-20 | 10,850 | $41.76 | $453.1K | 200,873 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2012-06-01 | 2012-06-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2012-02-02 | 2012-02-06 | 236,000 | — | $0 | 236,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2012-02-02 | 2012-02-06 | 47,201 | $0.01 | $472 | 267,601 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2011-02-06 | 2012-02-07 | 12,900 | $37.11 | $478.7K | 252,201 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2011-02-06 | 2012-02-07 | 2,500 | $36.39 | $91.0K | 265,101 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2011-02-06 | 2012-02-07 | 40,600 | $38.08 | $1.55M | 211,601 | SEC↗ |